- Home
- EEFT vs VKTX Comparison
EEFT vs VKTX Comparison
Compare EEFT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEFT
- VKTX
- Stock Information
- Founded
- EEFT 1994
- VKTX 2012
- Country
- EEFT United States
- VKTX United States
- Employees
- EEFT N/A
- VKTX N/A
- Industry
- EEFT EDP Services
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- EEFT Technology
- VKTX Health Care
- Exchange
- EEFT Nasdaq
- VKTX Nasdaq
- Market Cap
- EEFT 4.5B
- VKTX 5.6B
- IPO Year
- EEFT 1997
- VKTX 2015
- Fundamental
- Price
- EEFT $99.78
- VKTX $54.13
- Analyst Decision
- EEFT Strong Buy
- VKTX Strong Buy
- Analyst Count
- EEFT 9
- VKTX 9
- Target Price
- EEFT $124.63
- VKTX $111.78
- AVG Volume (30 Days)
- EEFT 286.0K
- VKTX 3.2M
- Earning Date
- EEFT 10-18-2024
- VKTX 10-23-2024
- Dividend Yield
- EEFT N/A
- VKTX N/A
- EPS Growth
- EEFT 10.79
- VKTX N/A
- EPS
- EEFT 5.79
- VKTX N/A
- Revenue
- EEFT $3,804,900,000.00
- VKTX N/A
- Revenue This Year
- EEFT $9.44
- VKTX N/A
- Revenue Next Year
- EEFT $8.10
- VKTX N/A
- P/E Ratio
- EEFT $17.23
- VKTX N/A
- Revenue Growth
- EEFT 7.99
- VKTX N/A
- 52 Week Low
- EEFT $73.84
- VKTX $8.28
- 52 Week High
- EEFT $117.66
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- EEFT 41.82
- VKTX 40.88
- Support Level
- EEFT $104.39
- VKTX $58.90
- Resistance Level
- EEFT $108.42
- VKTX $64.91
- Average True Range (ATR)
- EEFT 2.29
- VKTX 4.78
- MACD
- EEFT -0.26
- VKTX -1.12
- Stochastic Oscillator
- EEFT 1.48
- VKTX 13.29
About EEFT Euronet Worldwide Inc.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. The company operates an independent network of ATMs in Europe, along with a network for prepaid products such as mobile top-ups, and processes point-of-sale transactions. It operates in three segment EFT Processing Segment, epay Segment, and Money Transfer Segment. Its segment revenue comes from by operating income, electronical financial transaction processing, mainly generates revenue from monthly ATM management fees and currency conversion transactions. It generates the majority if its geographic revenue from the United States of America.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.